BRANMOOR
THURSDAY ยท 14 MAY 2026

FDA Recall D-0348-2026

Wizcure Pharmaa Private Limited · Bhiwadi, N/A

Class II Ongoing 134 days on record

Moderate impact — Class II recall โ€” temporary or medically reversible adverse health consequence possible; remote probability of serious adverse health consequence.

Product

Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief Revitalizing Formula, 10 ml (1/3 fl.oz.), Wizcure Pharmaa PVT. LTD., H-881, Phase 3, RIICO Industrial Area, Bhiwadi-301019, India, Manufactured for and distributed by: hi-health, 15207 N. 75th Street, Suite #104, Scottsdale, AZ 85260, NDC 77790-003-10.

Lot / code: All lots

Quantity: 11,520 cartons

Reason for recall

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Recall record

Recall number
D-0348-2026
Classification
Class II
Status
Ongoing
Voluntary or mandated
Voluntary: Firm initiated
Firm notification
Letter
Distribution
Distributed Nationwide in the USA
Recall initiated
2025-12-31
Classified by FDA Center
2026-02-25
FDA published
2026-03-04
Recalling firm
Wizcure Pharmaa Private Limited
Firm location
Bhiwadi, N/A, India

Drug identification

Brand name(s)
VISTA MEIBO TEARS PROPYLENE GLYCOL 0.6% W/V ADVANCED DRY EYE RELIEF LUBRICATING DROPS 10 ML
Generic name(s)
PROPYLENE GLYCOL
Manufacturer(s)
Red Wedding LLC
NDC(s)
77790-003
Route(s)
OPHTHALMIC

Operational response

Class II recalls indicate possible temporary or reversible health consequences. Remove affected lots from active dispensing. Segregate inventory. Check the firm’s recall notification for guidance on patient outreach.

For the official FDA enforcement record, see FDA's Recall Search.

‹ All recalls